Difference between revisions of "Profiles"
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
*[[QIBA Profile Template]] - <may provide useful explanations of what the structure/format/wording of profiles mean> | *[[QIBA Profile Template]] - <may provide useful explanations of what the structure/format/wording of profiles mean> | ||
*[[Committees]] - <text about in process drafts being available on the page of the Biomarker Cmte that is developing it> | *[[Committees]] - <text about in process drafts being available on the page of the Biomarker Cmte that is developing it> | ||
| + | *[[Conformance]] - <discussion of how sites and products claim conformance to a profile> | ||
Revision as of 20:21, 4 May 2016
Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.
Stage 3: Technically Confirmed
Stage 2: Publicly Reviewed
Stage 1: Public Comment
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)
See Also
- How to use QIBA Profiles
- Work Product for Review
- QIBA Profile Template - <may provide useful explanations of what the structure/format/wording of profiles mean>
- Committees - <text about in process drafts being available on the page of the Biomarker Cmte that is developing it>
- Conformance - <discussion of how sites and products claim conformance to a profile>